Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

Also called NCT03807037

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 250 participants (enrolled count) (from the registry)
Sponsor
Monash University Malaysia (from the registry)
Registry
  • NCT NCT03807037
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03807037. Randomized; triple masking; primary purpose prevention. Start 2018-12-17 (actual); primary completion 2021-12-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
Intervention (Dietary supplement)
Tocotrienols
Intervention (Drug)
Placebo oral capsule
Lead sponsor
Monash University Malaysia (class: other)
Collaborator
Institut Jantung Negara (class: other)

Record details

Record id
cardio:ct-nct03807037
Content hash
43bcdc9864f77bb0fe2b8b3ea620e9507808dd3eceac2b6bd89709568b3e118c